SEC Form D private-offering filing

EpiBone, Inc.

A new SEC Form D private-offering notice from New York, NY, a $4,300,506 filer-stated offering target in Biotech. The source filing is one click away.

EpiBone, Inc. site↗ Verified via SEC Form D

Biotechnology company that grows personalized living bone and cartilage grafts from a patient's own stem cells for reconstructive surgery

Filed 2025-10-24Filed to raise $4,300,506First money in 2025-09-02Raised so far $4,287,429HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified epibone.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.